Abstract Number: 1405 • 2012 ACR/ARHP Annual Meeting
Real World Experience Comparing Multiplex Immunobead Assay versus Immunoflorescence Assay for Anti-Nuclear Antibody Detection At a University Hospital
Background/Purpose: Anti-nuclear antibody (ANA) is considered a screening method for diagnosis of autoimmune disorders. Immunoflorescence ANA assay (IF) remains the gold standard for detection of…Abstract Number: 1406 • 2012 ACR/ARHP Annual Meeting
The Cost of Management of Adult Active Systemic Lupus Erythematosus in the UK
Background/Purpose: Several international studies have shown that systemic lupus erythematosus (SLE) has a considerable financial burden on patients and the health-care economy. Little recent information…Abstract Number: 1407 • 2012 ACR/ARHP Annual Meeting
The Effect of the Antiphospholipid Syndrome (APS) On Survival in Chinese Patients with SLE: A Prospective Study of 679 Patients
Background/Purpose: To study the effect of the antiphospholipid syndrome (APS) on survival in Chinese patients with SLE Methods: A cohort of 679 southern Chinese patients…Abstract Number: 1408 • 2012 ACR/ARHP Annual Meeting
Monitoring Patients with Systemic Lupus Erythematosus in Clinical Practice: Have You Already Checked the Vaccination Status in Your Patients?
Background/Purpose: : Infection is one of the main causes of morbidity and increased mortality in patients with systemic lupus erythematodes (SLE). Information about vaccination history and…Abstract Number: 1409 • 2012 ACR/ARHP Annual Meeting
A Multicentre Clinical Study of Umbilical Cord Mesenchymal Stem Cells Transplantation in Active Systemic Lupus Erythematosus
Background/Purpose: Umbilical cord (UC) derived mesenchymal stem cells (MSCs) have shown safety profile and therapeutic effect in severe and refractory systemic lupus erythematosus (SLE) in…Abstract Number: 1410 • 2012 ACR/ARHP Annual Meeting
Relationship Between Individual Organ Damage and Mortality of Systemic Lupus Erythematosus (SLE): A Prospective Cohort Study of 679 Patients
Background/Purpose: To study the relationship between damage in different organ systems and mortality in patients with SLE. Methods: 679 patients who fulfilled at least 4…Abstract Number: 1411 • 2012 ACR/ARHP Annual Meeting
Equivalence of Various Language Versions of Lupus Specific Patient Reported Outcomes Measure (LupusPRO)
Background/Purpose: Due to observed disparities in health outcomes in Systemic Lupus Erythematosus (SLE) across racial/ethnic groups, socioeconomic status, or health care systems, studies on group…Abstract Number: 1412 • 2012 ACR/ARHP Annual Meeting
Vascular Cell Adhesion Molecule (VCAM-1) and Angiostatin in Systemic Lupus Erythematosus
Background/Purpose: Vascular cell adhesion molecule-1 (VCAM-1), an adhesion molecule, is involved in the progression of glomerular and tubulointerstitial injury. High levels of VCAM-1 have been…Abstract Number: 1413 • 2012 ACR/ARHP Annual Meeting
Clinical Presentation, Treatment and Outcome of Membranous Nephropathy in SLE: A Comparison with Proliferative Lupus Glomerulonephritis in 141 Patients
Background/Purpose: To study the presentation and outcome of membranous nephropathy in SLE in comparison with proliferative lupus glomerulonephritis. Methods: Patients with biopsy firmed active lupus nephritis…Abstract Number: 1414 • 2012 ACR/ARHP Annual Meeting
Combination of Mycophenolate Mofetil and Tacrolimus for Refractory Lupus Nephritis: A 12-Month Open-Labeled Trial
Background/Purpose: To evaluate the efficacy and tolerability of a combination of mycophenolate mofetil (MMF) and tacrolimus (Tac) for refractory lupus nephritis Methods: Patients with refractory…Abstract Number: 1415 • 2012 ACR/ARHP Annual Meeting
Effect of Renal Disease On Survival of Patients with Systemic Lupus Erythematosus: A Prospective Cohort Study of 694 Patients
Background/Purpose: To study the effect of renal disease on survival and life expectancy of patients with systemic lupus erythematosus (SLE). Methods: Patients who fulfilled >=4…Abstract Number: 1376 • 2012 ACR/ARHP Annual Meeting
Development of A Health Index for Patients with Ankylosing Spondylitis – First Steps of A Global Initiative Based On the ICF Guided by ASAS
Background/Purpose: The burden of ankylosing spondylitis (AS) can be considerable. The patients suffer from pain, stiffness and fatigue, and they are limited in their activities…Abstract Number: 1377 • 2012 ACR/ARHP Annual Meeting
Prevalence of Spondyloarthritis-Related Comorbidities, Osteoporosis and Fractures in Ankylosing Spondylitis: a Systematic Literature Review
Background/Purpose: Comorbidities, both related and unrelated to the concept of spondyloarthritis (SpA), are common in patients with ankylosing spondylitis (AS) and may have substantial influence…Abstract Number: 1378 • 2012 ACR/ARHP Annual Meeting
Validity of Ankylosing Spondylitis Disease Activity Score (ASDAS) in Patients with Early Spondyloarthritis
Background/Purpose: Recently, a Working Group of the SpondyloArtrhitis International Society (ASAS) has proposed a composite disease activity score, the Ankylosing Spondylitis Disease Activity Score (ASDAS),…Abstract Number: 1379 • 2012 ACR/ARHP Annual Meeting
Ultrasonographic Is More Sensitive Than Traditional Clinical Evaluation in the Detection of Hands and Wrists Synovitis and Digital Soft Tissue Involvement in Early Psoriatic Arthritis
Background/Purpose: Background: Clinical measures are widely used in established psoriatic arthritis (PsA) but in early phase of disease, often fail to identify the joint and…